Need Help? Contact Us.

Enquire now


Appropriate patient management, IgM and IgG results from same sample tube
Screening patients for B19V antibody status will determine the need for further follow-up.
An IgG-positive, IgM-negative pregnant women should be reassured that B19V infection is not a cause for concern during their pregnancy.

Confidence in the results
Selected recombinant VP2 antigen for optimal test performance
Traceable to the WHO IS 01/602 for IgG, with results express in IU/mL.
No observed cross-reactivity with common viruses such as EBV, VZV and CMV

Streamlined workflow, rapid results and cost effective
Ready to use, 50 tests reagents cartridge with up to 60 days on-board storage.
Calibrate once every 21 days with common controls for both IgM and IgG assays
Suitable for use with serum or plasma (sodium heparin, sodium citrate, potassium EDTA) samples.

Interested? Enquire now.

This site is registered on as a development site.